MetaCap

Lycia Therapeutics Statistics

NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

33.07+1.30 (+4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lycia Therapeutics by the numbers

Lycia Therapeutics has a market capitalization of $1.72 billion based on 52.09M shares outstanding. With trailing EPS of $-1.04, Lycia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.0% above its 50-day average and 12.0% above its 200-day average.

Average daily trading volume is 432.72K shares, or about $14.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LYCA valuation vs. peer median

LYCA compared with the median of 8 peer companies
MetricLYCAPeer medianDifference
Market cap$1.72B$1.64B+5%
Avg. volume432.72K1.79M-76%

Peer median across 8 companies: MAZE, REPL, COAG, BCRX, VIR, RXRX, ALVO, WWB.

Valuation

Price and trading

Previous close
31.77
Open
31.86
Day range
31.01 – 34.59
52-week range
22.19 – 36.49
Beta
—
Volume
422.14K

Dividends and events

Additional statistics

Market Cap
1.72B
Forward Pe
-26.25
Eps
-1.04
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
36.49
Week52 Low
22.19
Avg Volume
432.72K
Shares Outstanding
52.09M
Ma50
29.52
Ma200
29.52
Pct From52w High
-9.37%
Pct From52w Low
49.03%

Related